4Filed Jul 15, 8:00 PM ET

Enova (ENVA) Exec Chairman David Fisher Exercises Options & Sells

$ENVA · Enova International, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Enova (ENVA) Exec Chairman David Fisher Exercises Options & Sells

What Happened

  • David Fisher, Executive Chairman and Director of Enova (ENVA), exercised stock-related derivatives and immediately sold the resulting shares in the open market. On July 14, he exercised 17,006 shares at $20.73 (cash paid ~$352,534) and sold those 17,006 shares at a weighted-average price of $231.51 for proceeds of ~$3,936,993. On July 15, he exercised 11,494 shares at $20.73 (cash paid ~$238,271) and sold those 11,494 shares at a weighted-average price of $231.45 for proceeds of ~$2,660,332. Aggregate proceeds from the sales were about $6.60M; aggregate exercise cost was about $591k.

Key Details

  • Transaction dates: July 14, 2026 and July 15, 2026.
  • Exercises (M): 17,006 shares @ $20.73 (7/14) and 11,494 shares @ $20.73 (7/15) — total exercised 28,500 shares.
  • Open-market sales (S): 17,006 shares @ weighted avg $231.51 (7/14) and 11,494 shares @ weighted avg $231.45 (7/15) — total sold 28,500 shares; total sales ~$6,597,325.
  • Derivative disposals at $0.00: same share counts (17,006 and 11,494) reported as disposals — these reflect the tandem SAR/option relationship (see footnotes).
  • Price ranges: 7/14 sales executed across prices $229.9452–$233.6532 (weighted avg reported). 7/15 sales ranged $225.64–$235.4298 (weighted avg reported).
  • Shares owned after transaction: not stated in the provided excerpt; net effect of these transactions = no net change in share count from the exercises and immediate sales (exercised 28,500 and sold 28,500).
  • Filing/timeliness: Report filed July 16, 2026 for transactions on July 14–15 — no indication in the filing that it was late.

Context

  • This was effectively an exercise-and-sell (cashless-style) transaction: Fisher paid the low exercise price ($20.73/share) to acquire shares and then sold them at ~ $231.5/share the same days. Footnotes explain that a limited stock appreciation right (SAR) and an employee option were granted in tandem and that exercise of one results in expiration of the other; the $0.00 disposals reflect that contractual interplay. The SAR’s payout depends on an “Offer Value Per Share” in specified change-in-control or offer events per the grant terms.